169 related articles for article (PubMed ID: 36339457)
41. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Dimopoulos MA; Trotman J; Tedeschi A; Matous JV; Macdonald D; Tam C; Tournilhac O; Ma S; Oriol A; Heffner LT; Shustik C; García-Sanz R; Cornell RF; de Larrea CF; Castillo JJ; Granell M; Kyrtsonis MC; Leblond V; Symeonidis A; Kastritis E; Singh P; Li J; Graef T; Bilotti E; Treon S; Buske C;
Lancet Oncol; 2017 Feb; 18(2):241-250. PubMed ID: 27956157
[TBL] [Abstract][Full Text] [Related]
42. An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis.
Møyner K; Sletten K; Husby G; Natvig JB
Scand J Immunol; 1980; 11(5):549-54. PubMed ID: 6155694
[TBL] [Abstract][Full Text] [Related]
43. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
Strachan AF; Johnson PM
J Clin Lab Immunol; 1982 Sep; 8(3):153-6. PubMed ID: 6813503
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary paraprotein production in Waldenström's macroglobulinaemia.
Hull RG; Barton EJ
Postgrad Med J; 1982 Jan; 58(675):57-8. PubMed ID: 6806789
[TBL] [Abstract][Full Text] [Related]
45. [Waldenström's macroglobulinemia and peripheral amyloid neuropathy (author's transl)].
Pennec Y; Youinou P; Lavel G; Le Goff P; Balouet G; Le Menn G
Ann Med Interne (Paris); 1981; 132(4):257-60. PubMed ID: 6272622
[TBL] [Abstract][Full Text] [Related]
46. Waldenstrom's macroglobulinaemia.
Jayapal V; Thomas M; Mathew S; Augustine J; Santhamma K; Vijayalekshmi N; Rajan GV; Chandrasekhar KP
J Assoc Physicians India; 1990 Jul; 38(7):510-2. PubMed ID: 2127274
[TBL] [Abstract][Full Text] [Related]
47. Nephrotic syndrome and kidney failure due to immunocomplex-mediated renal damage in a patient with Waldenström's Macroglobulinemia: a case report.
Castro H; Valenzuela R; Ruiz P; Lenz O; Monrroy M
Cases J; 2008 Nov; 1(1):333. PubMed ID: 19019245
[TBL] [Abstract][Full Text] [Related]
48. Waldenström's macroglobulinemia with pulmonary amyloidosis.
Zatloukal P; Bezdícek P; Schimonová M; Havlícek F; Tesarová P; Slováková A
Respiration; 1998; 65(5):414-6. PubMed ID: 9782228
[TBL] [Abstract][Full Text] [Related]
49. Hypercalcaemia due to calcium binding IgM paraprotein in Waldenström's macroglobulinaemia.
Side L; Fahie-Wilson MN; Mills MJ
J Clin Pathol; 1995 Oct; 48(10):961-2. PubMed ID: 8537499
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
[TBL] [Abstract][Full Text] [Related]
51. [A rare cause of pulmonary opacities: Lung localization of Waldenström's macroglobulinemia].
Monnet CM; Favrolt N; Bastie JN; Chrétien ML; Benoit F; Rossi C; Camus P; Bonniaud P
Rev Mal Respir; 2014 Sep; 31(7):632-5. PubMed ID: 25239587
[TBL] [Abstract][Full Text] [Related]
52. Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplant.
Muzaffar J; Katragadda L; Haider S; Abdallah AO; Anaissie E; Usmani SZ
Acta Haematol; 2013; 130(3):146-9. PubMed ID: 23689541
[TBL] [Abstract][Full Text] [Related]
53. Cast nephropathy in a case of Waldenström's macroglobulinemia.
Isaac J; Herrera GA
Nephron; 2002 Jul; 91(3):512-5. PubMed ID: 12119489
[TBL] [Abstract][Full Text] [Related]
54. Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study.
Furman RR; Eradat HA; DiRienzo CG; Hofmeister CC; Hayman SR; Leonard JP; Coleman M; Advani R; Chanan-Khan A; Switzky J; Liao QM; Shah D; Jewell RC; Lisby S; Lin TS
Lancet Haematol; 2017 Jan; 4(1):e24-e34. PubMed ID: 27914971
[TBL] [Abstract][Full Text] [Related]
55. Signet-ring cells in a Waldenström's Macroglobulinaemia.
Molero T; De La Iglesia S; Santana C; Lemes A; Matutes E
Leuk Lymphoma; 1998 Dec; 32(1-2):175-7. PubMed ID: 10037013
[TBL] [Abstract][Full Text] [Related]
56. Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia.
Luigetti M; Frisullo G; Laurenti L; Conte A; Madia F; Profice P; Batocchi AP; Montano N; Tarnani M; Tonali PA; Sabatelli M
J Neurol Sci; 2010 Apr; 291(1-2):89-91. PubMed ID: 20149395
[TBL] [Abstract][Full Text] [Related]
57. A Case of Waldenstrom's Macroglobulinemia Morphologically Resembling Plasma Cell Myeloma.
Uminski K; Houston BL; Moltzan C; Sun P
J Hematol; 2019 Mar; 8(1):26-28. PubMed ID: 32300437
[TBL] [Abstract][Full Text] [Related]
58. [Successful detection of MYD88 L265P mutation in Waldenström's macroglobulinemia complicated with myelofibrosis using highly sensitive digital PCR].
Nawata R; Sugiyama A; Harada K; Shinohara K; Yujiri T
Rinsho Ketsueki; 2019; 60(8):903-909. PubMed ID: 31484887
[TBL] [Abstract][Full Text] [Related]
59. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
[TBL] [Abstract][Full Text] [Related]
60. Waldenström's macroglobulinaemia presenting as isolated epistaxis: a common complaint but a rare cause.
Bakri K; Haydar AA; Davis J; Walt JW; Kazmi M; Goldsmith DJ
Int J Clin Pract; 2004 Jan; 58(1):81-2. PubMed ID: 14994975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
